Repotrectinib. ALK/ROS1/TRK inhibitor, Treatment of solid tumors
-
Published:2022
Issue:9
Volume:47
Page:661
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Li Z.,Bo L.,Talukder S.,Ping F-F.,Chen Z.-S.
Subject
Pharmacology (medical),Pharmacology